IP Library Granted Patent US 8,952,032
Granted Patent B2
US 8,952,032 · App. 14/032,648 · Granted Feb 10, 2015

Oligomer-opioid agonist conjugates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,952,032
App. No.
14/032,648
Granted
Feb 10, 2015
Kind
B2
Abstract

The invention provides compounds that are chemically modified by covalent attachment of a water-soluble oligomer. A compound of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from those of the compound not attached to the water-soluble oligomer.

Claims (18)

1. A compound having the formula:

wherein n is an integer having a value of from 1 to 30, and pharmaceutically acceptable salts thereof.

2. The compound of claim 1 , wherein n is 1.

3. The compound of claim 1 , wherein n is 2.

4. The compound of claim 1 , wherein n is 3.

5. The compound of claim 1 , wherein n is 4.

6. The compound of claim 1 , wherein n is 5.

7. The compound of claim 1 , wherein n is 6.

8. The compound of claim 1 , wherein n is 7.

9. The compound of claim 1 , wherein n is 8.

10. The compound of claim 1 , wherein n is 9.

11. The compound of claim 1 , wherein n is an integer from 1 to 10.

12. A composition comprising a compound of claim 1 and optionally, a pharmaceutically acceptable excipient.

13. The composition of claim 12 , wherein the composition is suitable for oral administration.

14. The composition of claim 12 , wherein the composition comprises about 0.001 mg to about 1000 mg of the compound.

15. The composition of claim 13 , in tablet, caplet, or capsule form.

16. A method of treating pain, comprising administering a therapeutically effective amount of a compound of claim 1 to a patient in need thereof.

17. A method of treating pain, comprising administering a composition of claim 12 to a patient in need thereof.

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2023
From: INHERIS BIOPHARMA, INC.
To: NEKTAR THERAPEUTICS
Reel/Frame 062313/0501 →
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: INHERIS BIOPHARMA, INC.
Reel/Frame 052435/0062 →
CHANGE OF NAME Recorded Nov 15, 2019
From: INHERIS PHARMACEUTICALS, INC.
To: INHERIS BIOPHARMA, INC.
Reel/Frame 051038/0585 →
SECURITY INTEREST Recorded Oct 28, 2019
From: INHERIS PHARMACEUTICALS, INC.
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 050846/0940 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2019
From: NEKTAR THERAPEUTICS
To: INHERIS PHARMACEUTICALS, INC.
Reel/Frame 050846/0461 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 31838, FRAME 0343 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036876/0138 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2014
From: RIGGS-SAUTHIER, JENNIFER; DENG, BO-LIANG; RILEY, TIMOTHY A.
To: NEKTAR THERAPEUTICS
Reel/Frame 032634/0453 →
SECURITY AGREEMENT Recorded Dec 18, 2013
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 031838/0343 →